Skip Navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Are Blood Borne Cancers Treatable with Stem Cell Techniques or other New Advances?

Loading video...

Air date: Monday, June 20, 2005, 11:00:00 AM
Time displayed is Eastern Time, Washington DC Local
Views: Total views: 90 * This only includes stats from October 2011 and forward.
Category: Special
Runtime: 02:05:57
Description: NCI and Dana-Farber Science Writers’ Seminar

Welcome and Message from Dana-Farber’s Director on its role as an NCI-Designated Comprehensive Cancer Center

Ken Anderson, M.D., Dana-Farber – Multiple Myeloma: New therapies using old drugs (e.g., thalidomide)

Robert Soiffer, M.D., Dana-Farber – Stem Cell Transplantation as a Tool for Treating Blood-borne Cancers

Mr./Mrs. X (Patient at Dana-Farber) – What it means to be a survivor of a blood-borne cancer and the role of Dana-Farber in treatment

Wyndam Wilson, M.D. – The latest advances in leukemia research and where the cancer community is headed in treating blood-borne cancers
NLM Title: Are blood borne cancers treatable with stem cell techniques or other new advances? / Wyndham Wilson, Ken Anderson, and Robert Soiffer.
Author: Wilson, Wyndham Hopkins.
National Cancer Institute (U.S.)
Publisher:
Abstract: (CIT): NCI and Dana-Farber science writers' seminar. Welcome and message from Dana-Farber's director on its role as an NCI-designated comprehensive cancer center / Ken Anderson -- Multiple myeloma: new therapies using old drugs (e.g., thalidomide) / Robert Soiffer -- Stem cell transplantation as a tool for treating blood-borne cancers / Mr./Mrs. X (patient at Dana-Farber) -- What it means to be a survivor of a blood-borne cancer and the role of Dana-Farber in treatment / Wyndam Wilson -- The latest advances in leukemia research and where the cancer community is headed in treating blood-borne cancers.
Subjects: Antineoplastic Agents
Neoplasms--therapy
Stem Cells
Publication Types: Lecture
Webcast
NLM Classification: QZ 266
NLM ID: 101268815
CIT Live ID: 4092
Permanent link: https://videocast.nih.gov/watch=4092

Related Videos...

Click Here to Play Video.
06:15:45
NIH Consensus Development Conference on Adjuvant Therapy for Breast Cancer (Day 2)
[Conferences]
11/2/2000
Click Here to Play Video.
07:10:29
National Cancer Advisory Board
[National Cancer Advisory Board]
5/22/2001
Click Here to Play Video.
07:44:33
NCI - Board of Scientific Advisors (Day 1)
[NCI Board of Scientific Advisors]
11/14/2002
Click Here to Play Video.
07:14:16
National Cancer Advisory Board (NCAB) September 2004 - Day 1
[National Cancer Advisory Board]
9/14/2004
Click Here to Play Video.
04:58:17
NIH Director's Pioneer Award 2007
[Conferences]
9/19/2007
Click Here to Play Video.
08:18:26
Recombinant DNA Advisory Committee (RAC) March 2007
[Recombinant DNA Advisory Committee]
3/14/2007
Click Here to Play Video.
06:43:50
Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) - Day 1
[Advisory Boards and Councils]
10/29/2009
Click Here to Play Video.
06:51:32
NIH State-of-the-Science Conference: Enhancing Use and Quality of Colorectal Cancer Screening - Day 1
[Conferences]
2/2/2010
Click Here to Play Video.
06:01:30
NCI - Board of Scientific Advisors (Day 1) - Afternoon Session
[NCI Board of Scientific Advisors]
3/3/2003
Click Here to Play Video.
07:15:40
Cancer Researchers and CAM Practitioners: Fostering Collaboration; Advancing the Science (Day 1)
[Conferences]
10/22/2007